Discover 243 paid clinical trials in Syracuse, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Syracuse is the medical research centre of central New York, and most of its trial activity runs through one institution: SUNY Upstate Medical University, the region's only academic medical centre and the largest employer in central New York. Cancer research leads the list, with ovarian cancer, lung cancer, and lymphoma studies recruiting through both cooperative groups such as the Alliance for Clinical Trials in Oncology and the National Cancer Institute and through industry sponsors, and migraine and Crohn's disease studies appear alongside them.
Filter
2
Filter results
Results: 243
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
for
Locally Advanced Cervical Adenocarcinoma,
Location: Syracuse NY, Verona NY, Oswego NY, Dickson City PA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07061977
Phase3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
for
Epilepsy, Temporal Lobe
Location: Syracuse NY, Charlottesville VA, Durham NC,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06422923
Phase1, Phase2, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Syracuse NY, Rochester NY, Hackensack NJ, The Bronx NY,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase2, Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
for
Non-small Cell Lung Cancer
Location: Syracuse NY, Rochester NY, New York NY, Lancaster PA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06561386
Phase3, Recruiting
InterFuse® S and T for the Treatment of Scoliosis, Spondylolisthesis and Degenerative Disc Disease (DDD)